Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Closed-End Fund
  • Objective: Technology Sector
  • Asset Class: Equity
  • Geographic Focus: Global

New Venturetec Ltd/fund

+ Add to Watchlist

NVC:GR

5.0560 EUR 0.0170 0.34%

As of 10:05:16 ET on 04/24/2015.

Snapshot for New Venturetec Ltd/fund (NVC)

Open: 5.2430 High - Low: 5.3000 - 5.0370 Primary Exchange: Berlin
Volume: 0 52-Week Range: 3.3000 - 5.4840 Beta vs DAX: 0.5003

ETF Chart for NVC

No chart data available.
  • NVC:GR 5.3000
  • 1D
  • 1M
  • 1Y
5.0390
Interactive NVC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for NVC

New Venturetec Ltd. is a listed Swiss investment company, which provides direct investment access to early stage, high quality US companies in the areas of biotechnology, communications, technology, and the Internet. The portfolio is actively managed. The objective is to generate absolute return for shareholders.

Inception Date: 1998-05-08 Telephone: +41 1 283 2900
Managers: PETER FRIEDLI
Web Site: www.newventuretec.com

Fundamentals for NVC

NAV (on 2007-09-28) 26.1800
Assets (M) (on 2008-06-30) 102.5000
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for NVC

No dividends reported

Performance for NVC

1-Month -3.40% 1-Year +23.02%
3-Month -2.83% 3-Year +68.60%
Year To Date +53.21% 5-Year +10.60%
Expense Ratio -

Top Fund Holdings for NVC

Filing Date: 03/02/2015
Name Position Value % of Total
Osiris Therapeutics Inc 4,103,301 71,315,371 112.562%
mPortal Inc 25,825,000 8,156,880 12.875%
Myriad Genetics Inc 180,400 6,041,596 9.536%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil